The story at FICO has moved from a valuation reset to a credibility test, with Bank of America becoming the first major firm to pull its Buy rating as the stock trades at roughly half of where the Street's price targets still sit.
B of A's Curtis Nagle downgraded to Neutral and cut his target to $700 from $1,400 on Tuesday, a 50% reduction that marks the starkest acknowledgment yet that the previous consensus was built on assumptions that no longer hold. The move matters because it breaks the pattern every other firm has followed since the July 29 earnings collapse: cut the target hard, but keep the positive rating. Barclays took its target to $935 from $1,700, Wells Fargo to $950 from $1,350, and BMO Capital to $1,150 from $1,550, all in the same session, all while maintaining Overweight or Outperform ratings. The result is a consensus that reads "buy" in aggregate, with eight Buy ratings against seven Holds, yet a mean target of $1,256 against a stock trading at $617.87. That two-to-one gap between the word and the number is not a signal of conviction; it is a signal that the Street has not yet agreed on where the floor is.
The positioning picture does not look like a crowded short, which is one of the few things working in the bulls' favour. Short interest is at 7.8% of free float, up 8% on the week and edging higher from the low-to-mid 7% range that persisted through most of September. That is a meaningful position but not an extreme one. Borrow availability is ample, at 671% relative to shares already borrowed, far above the 52-week low of 194%, and the cost to borrow is negligible at around 0.5%. There is no evidence of a short-driven squeeze scenario building. The ORTEX short score has also drifted lower over the past two weeks, from 55.7 to 51.9, suggesting the incremental short pressure has eased even as the stock continued to fall.
Options traders have turned noticeably less defensive in the past week, which adds a counterpoint to the bearish price action. The put/call ratio closed at 0.85 on Tuesday, below its 20-day mean of 0.89 and at the lower end of the range seen through September. Earlier in the month the ratio was running close to 0.98. That shift is consistent with the idea that investors who wanted downside protection have already put it on, rather than with fresh panic being layered into the market. Wikipedia page views for FICO are running at a z-score of 2.4 against the prior 90 days, indicating a sharp spike in retail attention around the collapse, a pattern that often accompanies sharp drawdowns rather than foreshadowing further selling.
Capital Research and Management holds 15.1% of shares and added 702,000 shares in the period ending August 31. Arrowstreet Capital added 156,000 shares in the same period. Those additions preceded the worst of the decline, so they reflect neither capitulation nor a fresh buying decision at current prices. The Vanguard Group filed a 13G/A in March 2026 showing its stake had fallen to zero from 12.78%, a notable exit from one of the stock's largest historical holders, though the disclosure caveat applies: positions are as last disclosed around the 5% threshold. No 13D activist holder is on the register. On the insider front, the only open-market activity in the recent EDGAR record is a director sale under a 10b5-1 plan in late July at around $1,400, a pre-arranged transaction that carried no discretionary signal, made at a price that now looks very far away.
The next earnings print is scheduled for November 6, giving the company 37 days to either stem the narrative or face another test. History on this name is not encouraging: the July 29 release produced a 14.7% single-day loss and an 18.3% decline over the following five sessions, and the print before that generated an 8.3% single-day drop. The question heading into November is whether the recent analyst target cuts have already priced in whatever structural concern drove those misses, or whether the gap between the $1,256 mean target and a $618 stock means the Street still has further to revise.
See the live data behind this article on ORTEX.
Open FICO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
